Thyrocare Technologies Ltd Q1 FY25 consolidated profit climbs to Rs. 24.17 crores

Thyrocare Technologies Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 160.53 crores during the period ended June 30, 2024 as compared to Rs. 157.74 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 24.17 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 17.78 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 4.51 for the period ended June 30, 2024 as compared to Rs. 3.54 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 160.53 crs	₹157.74 crs	1.77%
Net Profit	₹24.17 crs	₹17.78 crs	35.94%
EPS	₹4.51	₹3.54	27.40%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 160.53 crores during the period ended June 30, 2024 as compared to Rs.135.87 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.24.17 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.17.30 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.4.51 for the period ended June 30, 2024 as compared to Rs.3.25 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 160.53 crs	₹135.87 crs	18.15%
Net Profit	₹24.17 crs	₹17.30 crs	39.71%
EPS	₹4.51	₹3.25	38.77%

Shares of Thyrocare Technologies Limited was last trading in BSE at Rs. 650.10 as compared to the previous close of Rs. 642.50. The total number of shares traded during the day was 2930 in over 383 trades.

The stock hit an intraday high of Rs. 659.95 and intraday low of 638.95. The net turnover during the day was Rs. 1902541.00.

Source : Equity Bulls

Keywords

ThyrocareTechnologies Q1FY25 FY2025 Q1FY2025 ResultUpdate